NCT01534195View on ClinicalTrials.gov

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Prednisolone Sodium Phosphate Ophthalmic Solution 1%

One drop in each eye, four times/day for 8 days.

DRUG

Tears Naturale II Ophthalmic Solution

one drop in each eye, four times/ day (QID) for 8 days

Trial Locations (1)

01810

Andover Eye Associates, Andover

All Listed Sponsors
lead

ORA, Inc.

INDUSTRY

NCT01534195 - Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model | Biotech Hunter | Biotech Hunter